29 related articles for article (PubMed ID: 24947100)
1. Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice.
Noronha V; Dhanawat A; Patil VM; Menon N; Singh AK; Chaturvedi P; Pai P; Chaukar D; Laskar SG; Prabhash K
Oral Oncol; 2024 Jan; 148():106633. PubMed ID: 37988838
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy in Locally Advanced Sinonasal Teratocarcinosarcoma a Rare Malignancy: An Audit From an Academic Tertiary Care Centre in India.
Peelay Z; Saha S; Patil V; Menon N; Singh A; Shah M; Sahu A; Ubharay A; Chowdhury OR; Prabhash K; Noronha V
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e137-e145. PubMed ID: 38565457
[TBL] [Abstract][Full Text] [Related]
3. Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center.
Agrawal M; Konduru V; Riju J; Singh A; Joel A; Karuppusami R; Tirkey AJ
South Asian J Cancer; 2023 Oct; 12(4):341-348. PubMed ID: 38130286
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for locally advanced head and neck squamous cell carcinoma - Is it still relevant? A practice pattern survey among oncologists of India.
Bandyopadhyay A; Goswami U; Ghosh P; Das P; Mandal S
J Cancer Res Ther; 2023; 19(5):1316-1323. PubMed ID: 37787301
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a tertiary hospital in Saudi Arabia.
Alessa M; Alhifany AA; Almatrafi NA; Bahaj AS; Alkaf HH; Alharbi J; Almaghrabi MY; Alsubaie HM; Elkhatib H; Albadainah F; Abdelmonim S
Saudi Pharm J; 2024 Jan; 32(1):101885. PubMed ID: 38077121
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for advanced oral cavity cancer.
Yaniv D; Seiwert TY; Margalit DN; Williams MD; Barbon CEA; Largo RD; Smith JA; Gross ND
CA Cancer J Clin; 2024; 74(3):213-223. PubMed ID: 38329372
[No Abstract] [Full Text] [Related]
7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
8. Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
Nicolau UR; de Jesus VHF; Lima ENP; Alves MS; de Oliveira TB; Andrade LB; Silva VS; Bes PC; de Paiva TF; Calsavara VF; Guimarães APG; Cezana L; Barbosa PNVP; Porto GCLM; Pellizzon ACA; de Carvalho GB; Kowalski LP
PLoS One; 2018; 13(8):e0200823. PubMed ID: 30114190
[TBL] [Abstract][Full Text] [Related]
9. What is the way forward for unresectable oral cavity cancers among Indian patients?
Chakraborty S
South Asian J Cancer; 2015; 4(1):3. PubMed ID: 25839009
[No Abstract] [Full Text] [Related]
10. Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.
Patil VM; Noronha V; Joshi A; Banavali SD; Muddu V; Prabhash K
Oncology; 2016; 91 Suppl 1():35-40. PubMed ID: 27463093
[TBL] [Abstract][Full Text] [Related]
11. Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.
Patil VM; Noronha V; Joshi A; Abhyankar A; Menon N; Dhumal S; Prabhash K
Oral Oncol; 2020 Jun; 105():104673. PubMed ID: 32272385
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL;
N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
Shim HJ; Cho SH; Hwang JE; Bae WK; Song SY; Cho SB; Lee WS; Joo YE; Na KJ; Chung IJ
Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
